Daniel M. Moldaver
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Long-term steroid-sparing effect of belimumab in systemic lupus erythematosus: Post hoc pooled analysis of OBSErve multi-country cohort data.
Journal: Lupus
Published: March 02, 2026
Retrospective database analysis to assess treatment patterns, clinical outcomes, and healthcare resource utilization in metastatic or recurrent HER2-positive breast cancer in Alberta.
Journal: Cancer treatment and research communications
Published: March 20, 2025
Programmed Cell Death-Ligand 1 Expression and Clinical Outcomes Among Patients with Resected, Early-Stage Non-Small Cell Lung Cancer: A Real-World Study.
Journal: Current oncology (Toronto, Ont.)
Published: August 26, 2024
Correction: Real-World Treatment Patterns and Survival Among Patients with Stage I-III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment.
Journal: Oncology and therapy
Published: April 16, 2024
Real-World Treatment Patterns and Survival Among Patients with Stage I-III, Non-Squamous, Non-Small Cell Lung Cancer Receiving Surgery as Primary Treatment.
Journal: Oncology and therapy
Published: January 26, 2024
Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020.
Journal: Breast cancer research and treatment
Published: August 24, 2023
Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study.
Journal: Frontiers in oncology
Published: March 22, 2023
Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada.
Journal: Frontiers in oncology
Published: March 22, 2023
Evaluation of Cost-Effectiveness of Adjuvant Osimertinib in Patients with Resected EGFR Mutation-Positive Non-small Cell Lung Cancer.
Journal: PharmacoEconomics - open
Published: January 30, 2023
A real-world retrospective analysis of the management of metastatic castrate-resistant prostate cancer in Ontario, Canada from 2010 - 2018.
Journal: Urologic oncology
Published: July 06, 2022
EGFR mutation prevalence, real-world treatment patterns, and outcomes among patients with resected, early-stage, non-small cell lung cancer in Canada.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 27, 2022
Last Updated: 09/26/2026